Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 3Gliosarcoma 3Glioblastoma 3Ependymoma 3Astrocytoma 3Pinealoma 2Neuroectodermal Tumors, Primitive 2Meningioma 2Medulloblastoma 2Glioma 2Choroid Plexus Neoplasms 2Brain Neoplasms 2Multiple Sclerosis 1Glioma, Subependymal 1Craniopharyngioma 1Central Nervous System Neoplasms 1

Interventions

Temozolomide 58Radiotherapy 50Carmustine 23Carboplatin 18Filgrastim 17Chemotherapy, Adjuvant 17Irinotecan 12Surgical Procedures, Operative 11Peripheral Blood Stem Cell Transplantation 11O(6)-benzylguanine 10Magnetic Resonance Spectroscopy 10Drug Therapy 10Etoposide 9sargramostim 8Thiotepa 8Thalidomide 8Cyclophosphamide 8Bevacizumab 8Procarbazine 7Gene Expression Profiling 7Erlotinib Hydrochloride 7Radiation 6Everolimus 6Cisplatin 6motexafin gadolinium 5aldesleukin 5Topotecan 5Imatinib Mesylate 5Celecoxib 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Gadolinium DTPA × Sarcoma × Clear all
NCT00005790 2012-06-11

Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors

Northwestern University

Phase NA Withdrawn
CNSSarcoma

Astrocytoma, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡